Si306
Si306 is a Src inhibitor with antitumor activity. Si306 reduces the phosphorylation of focal adhesion kinase (FAK) and the expression of epidermal growth factor receptor (EGFR), and inhibits the invasion of human glioblastoma (GBM) [1].
Product Specifications
CAS Number
1640012-88-9
UNSPSC
12352005
Target
EGFR; FAK; Src
Type
Reference compound
Related Pathways
JAK/STAT Signaling; Protein Tyrosine Kinase/RTK
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/si306.html
Smiles
BrC1=CC(NC2=NC(SCCN3CCOCC3)=NC4=C2C=NN4CC(Cl)C5=CC=CC=C5)=CC=C1
Molecular Formula
C25H26BrClN6OS
Molecular Weight
573.94
References & Citations
[1]Nešović, et al. "Src Inhibitors Pyrazolo [3, 4-d] pyrimidines, Si306 and Pro-Si306, inhibit focal adhesion kinase and suppress human glioblastoma invasion in vitro and in vivo." Cancers 12.6 (2020) : 1570.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
451866-01 10 mg
Hexakis (1H,1H,8H-tetradecafluorooctyloxy) phosphazine
Sign In for Pricing
View Details 451866-02 25 mg
Hexakis (1H,1H,8H-tetradecafluorooctyloxy) phosphazine
Sign In for Pricing
View Details 
